PHASE II STUDY OF DURVALUMAB (ANTI-PD-L1) COMBINED WITH EITHER R-CHOP OR LENALIDOMIDE AND R-CHOP IN PREVIOUSLY UNTREATED, HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA
Jaeger, U., Kalakonda, N., Everaus, H., Fustier, P., Jaeger, J., Manzke, O., Nowakowski, G.S.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2440_1
Date:
June, 2017
File:
PDF, 83 KB
english, 2017